Zobrazeno 1 - 10
of 628
pro vyhledávání: '"Massimo Aglietta"'
Autor:
Sara Lonardi, Eric Van Cutsem, Pilar Garcia-Alfonso, Mark Wong, Fabio Gelsomino, Bassel El-rayes, Michael J Overman, Andrew G Hill, Ming Lei, Massimo Aglietta, Maria Luisa Limon Miron, Gregory Leonard, Antonio Cubillo Gracian, Stephen M McCraith, Beilei He
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Programmed death-1 (PD-1) inhibitors, including nivolumab, have demonstrated long-term survival benefit in previously treated patients with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer
Externí odkaz:
https://doaj.org/article/8837ecde8e2f4b09ba632cfba21417dd
Autor:
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, Ilenia Iaia, Chiara Donini, Annamaria Massa, Maria Laura Centomo, Marco Basiricò, Elisa Vigna, Alberto Pisacane, Franco Picciotto, Enrico Berrino, Caterina Marchiò, Alessandra Merlini, Luca Paruzzo, Stefano Poletto, Daniela Caravelli, Andrea Michela Biolato, Valentina Bortolot, Elisa Landoni, Marco Ventin, Cristina R. Ferrone, Massimo Aglietta, Gianpietro Dotti, Valeria Leuci, Fabrizio Carnevale-Schianca, Dario Sangiolo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-13 (2023)
Abstract Background Even acknowledging the game-changing results achieved in the treatment of metastatic melanoma with the use of immune checkpoint inhibitors (ICI), a large proportion of patients (40–60%) still fail to respond or relapse due to th
Externí odkaz:
https://doaj.org/article/3eb42d63a9594f5d95b1ee9f44199df2
Autor:
Daniela Clerici, Carmine Liberatore, Paola Maria Rancoita, Chiara Maria Dellacasa, Francesca Patriarca, Paolo Corradini, Riccardo Saccardi, Angelo Michele Carella, Stella Santarone, Maurizio Musso, Anna Paola Iori, Patrizia Chiusolo, Francesco Onida, Nicola Mordini, Marco De Gobbi, Piero Galieni, Mario Luppi, Massimo Aglietta, Daniele Vallisa, Gabriella Storti, Luca Facchini, Jacopo Peccatori, Annalisa Ruggeri, Raffaella Greco, Consuelo Corti, Francesca Bonifazi, Fabio Ciceri
Publikováno v:
HemaSphere, Vol 7, p e987614b (2023)
Externí odkaz:
https://doaj.org/article/957da9c224994ecd8cf28d1dc6581af9
Autor:
Andrea Casadei-Gardini, Francesco Leone, Giovanni Brandi, Mario Scartozzi, Nicola Silvestris, Daniele Santini, Luca Faloppi, Massimo Aglietta, Maria Antonietta Satolli, Alessandro Rizzo, Sara Lonardi, Giuseppe Aprile, Lorenzo Fornaro
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Cholangiocarcinoma is a rare group of tumors that involve the hepatic biliary tree. Prognosis for patients with cholangiocarcinoma remains dismal. Herein, we present survival trends over a long time period spanning almost 20 years in patients with ad
Externí odkaz:
https://doaj.org/article/2dd82f13fde5441c8d4c22214c5ce10b
Autor:
Enrico Berrino, Roberto Filippi, Clara Visintin, Serena Peirone, Elisabetta Fenocchio, Giovanni Farinea, Franco Veglio, Massimo Aglietta, Anna Sapino, Matteo Cereda, Rosella Visintin, Barbara Pasini, Caterina Marchiò
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-9 (2022)
Abstract The onset of multiple and metachronous tumors in young patients induces to suspect the presence of genetic variants in genes associated with tumorigenesis. We describe here the unusual case of a 16-year-old patient who developed a synchronou
Externí odkaz:
https://doaj.org/article/0dc23024ce6348309ded7e0db960bd7f
Autor:
Massimo Berger, Marta Barone, Fabrizio Carnevale-Schianca, Marco De Gobbi, Paolo Nicoli, Daniela Caravelli, Daniela Cilloni, Luca Paruzzo, Manuela Spadea, Katia Mareschi, Massimo Aglietta, Franca Fagioli
Publikováno v:
Transplantology, Vol 3, Iss 1, Pp 51-67 (2022)
HSCT from an unrelated HLA-mismatched donor (MMUD) is one of the alternatives where an HLA-matched donor is not found. The aim of this study was to compare GvHD prophylaxis with anti-thymocyte globulin (ATG) vs. post-transplant cyclophosphamide (PT-C
Externí odkaz:
https://doaj.org/article/b0322e7c3c364a9faaa4cc6f479bcab1
Autor:
Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio, Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto, Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta, Angelo Paolo Dei Tos, Marta Sbaraglia, Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAdvanced and unresectable bone and soft tissue sarcomas (BSTS) still represent an unmet medical need. We demonstrated that the alkylating agent trabectedin and the PARP1-inhibitor olaparib display antitumor activity in BSTS preclinical mode
Externí odkaz:
https://doaj.org/article/6963744e31cd41adb03a55107319c8e2
Autor:
Giuliana Cavalloni, Caterina Peraldo-Neia, Annamaria Massa, Carlo Bergamini, Alessandro Trentini, Giovanni De Rosa, Lorenzo Daniele, Fabiola Ciccosanti, Carlo Cervellati, Francesco Leone, Massimo Aglietta
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outco
Externí odkaz:
https://doaj.org/article/b660554e9bb54e16972c21804eb76fd5
Autor:
Annamaria Massa, Caterina Peraldo-Neia, Francesca Vita, Chiara Varamo, Marco Basiricò, Chiara Raggi, Paola Bernabei, Jessica Erriquez, Ivana Sarotto, Francesco Leone, Serena Marchiò, Giuliana Cavalloni, Massimo Aglietta
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The treatment of unresectable cholangiocarcinoma (CCA) is limited by the development of resistance to conventional first-line chemotherapy based on gemcitabine (GEM). In addition, a prior treatment with GEM frequently induces cross-resistance to othe
Externí odkaz:
https://doaj.org/article/4ca669a711f344dbb310548605d05bd9
Autor:
Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte, Rebecca Senetta, Massimo Aglietta, Fulvio Borella, Anna Sapino, Dionyssios Katsaros, Furio Maggiorotto, Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Chiara Eusebi, Marina Momi, Paola Cassoni, Giorgio Valabrega
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background Central nervous system (CNS) spreading from epithelial ovarian carcinoma (EOC) is an uncommon but increasing phenomenon. We previously reported in a small series of 11 patients a correlation between Androgen Receptor (AR) loss and
Externí odkaz:
https://doaj.org/article/90a412445b4f442b9c28c61a06a3d2a9